March PBS listings climb to 12

Posted 3 March 2025 AM 

Twelve submissions recommended by the PBAC have landed on the PBS this month, including a new indication for AbbVie’s Skyrizi given the go-ahead three years ago.

As of the 1 March, the IL-23 inhibitor will be available on the PBS via a pre-filled-pen for adults with severe psoriatic arthritis. Patients require four doses per year after two initial starter doses.

To see the whole article, please login